Skip to main content
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
1. M. van Herk, “Errors and margins in radiotherapy,” Semin. Radiat. Oncol. 14, 5264 (2004).
2. D. A. Jaffray, “Image-guided radiation therapy: From concept to practice,” Semin. Radiat. Oncol. 17, 243244 (2007).
3. A. Bujold, T. Craig, D. Jaffray, and L. A. Dawson, “Image-guided radiotherapy: Has it influenced patient outcomes?,” Semin. Radiat. Oncol. 22, 5061 (2012).
4. C. F. Njeh, “Tumor delineation: The weakest link in the search for accuracy in radiotherapy,” J. Med. Phys. 33, 136140 (2008).
5. C. Rasch, R. Steenbakkers, and M. van Herk, “Target definition in prostate, head and neck,” Semin. Radiat. Oncol. 15, 136145 (2005).
6. E. Weiss and C. F. Hess, “The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences,” Strahlenther. Onkol. 179, 2130 (2003).
7. F. Buettner, S. L. Gulliford, S. Webb, M. R. Sydes, D. P. Dearnaley, and M. Partridge, “Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: An analysis of data from the MRC RT01 trial (ISRCTN 47772397),” Phys. Med. Biol. 54, 65356548 (2009).
8. X. A. Li, A. Tai, D. W. Arthur, T. A. Buchholz, S. Macdonald, L. B. Marks, J. M. Moran, L. J. Pierce, R. Rabinovitch, A. Taghian, F. Vicini, W. Woodward, and J. R. White, “Variability of target and normal structure delineation for breast cancer radiotherapy: An RTOG multi-institutional and multiobserver study,” Int. J. Radiat. Oncol., Biol., Phys. 73, 944951 (2009).
9. A. C. Riegel, A. M. Berson, S. Destian, T. Ng, L. B. Tena, R. J. Mitnick, and P. S. Wong, “Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion,” Int. J. Radiat. Oncol., Biol., Phys. 65, 726732 (2006).
10. M. J. Zelefsky, M. Kollmeier, B. Cox, A. Fidaleo, D. Sperling, X. Pei, B. Carver, J. Coleman, M. Lovelock, and M. Hunt, “Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. 84, 125129 (2012).
11. H. P. Soares et al., “Evaluation of new treatments in radiation oncology: Are they better than standard treatments?,” J. Am. Med. Assoc. 293, 970978 (2005).
12. M. Van Herk, “Will IGRT live up to its promise?,” Acta Oncol. 47, 11861187 (2008).
13. B. Engels, G. Soete, D. Verellen, and G. Storme, “Conformal arc radiotherapy for prostate cancer: Increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers,” Int. J. Radiat. Oncol., Biol., Phys. 74(2), 388391 (2009).
14. G. S. Mageras and J. Mechalakos, “Planning in the IGRT context: Closing the loop,” Semin. Radiat. Oncol. 17, 268277 (2007).
15. S. H. Benedict et al., “Stereotactic body radiation therapy: The report of AAPM Task Group 101,” Med. Phys. 37, 40784101 (2010).
16. K. E. Rusthoven et al., “Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases,” J. Clin. Oncol. 27, 15721578 (2009).
17. R. Timmerman et al., “Stereotactic body radiation therapy for inoperable early stage lung cancer,” J. Am. Med. Assoc. 303, 10701076 (2010).

Data & Media loading...


Article metrics loading...



There is no abstract available for this article.


Full text loading...


Access Key

  • FFree Content
  • OAOpen Access Content
  • SSubscribed Content
  • TFree Trial Content
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd